114 related articles for article (PubMed ID: 8968366)
21. Subtypes of neuronal nicotinic acetylcholine receptors involved in nicotine-induced phosphorylation of extracellular signal-regulated protein kinase in PC12h cells.
Nakayama H; Shimoke K; Isosaki M; Satoh H; Yoshizumi M; Ikeuchi T
Neurosci Lett; 2006 Jan; 392(1-2):101-4. PubMed ID: 16219421
[TBL] [Abstract][Full Text] [Related]
22. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
Ambrose V; Miller JH; Dickson SJ; Hampton S; Truman P; Lea RA; Fowles J
Nicotine Tob Res; 2007 Aug; 9(8):793-9. PubMed ID: 17654292
[TBL] [Abstract][Full Text] [Related]
23. Nicotinic and muscarinic acetylcholine receptors are essential for the long-term response of tyrosine hydroxylase gene expression to chronic nicotine treatment in rat adrenal medulla.
Yoshimura R; Xu L; Sun B; Tank AW
Brain Res Mol Brain Res; 2004 Jul; 126(2):188-97. PubMed ID: 15249143
[TBL] [Abstract][Full Text] [Related]
24. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of ethanol-induced ataxia by alpha(4)beta(2) nicotinic acetylcholine receptor subtype in mouse cerebellum: a functional interaction.
Taslim N; Al-Rejaie S; Saeed Dar M
Neuroscience; 2008 Nov; 157(1):204-13. PubMed ID: 18812210
[TBL] [Abstract][Full Text] [Related]
26. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
Grinevich VP; Crooks PA; Sumithran SP; Haubner AJ; Ayers JT; Dwoskin LP
J Pharmacol Exp Ther; 2003 Sep; 306(3):1011-20. PubMed ID: 12766255
[TBL] [Abstract][Full Text] [Related]
27. Effect of chronic nicotine treatment on localization of neuronal nicotinic acetylcholine receptors at cellular level.
Pakkanen JS; Stenfors J; Jokitalo E; Tuominen RK
Synapse; 2006 Jun; 59(7):383-93. PubMed ID: 16485261
[TBL] [Abstract][Full Text] [Related]
28. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
29. The activation and inhibition of human nicotinic acetylcholine receptor by RJR-2403 indicate a selectivity for the alpha4beta2 receptor subtype.
Papke RL; Webster JC; Lippiello PM; Bencherif M; Francis MM
J Neurochem; 2000 Jul; 75(1):204-16. PubMed ID: 10854263
[TBL] [Abstract][Full Text] [Related]
30. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
[TBL] [Abstract][Full Text] [Related]
31. Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
Marks MJ; Bullock AE; Collins AC
J Pharmacol Exp Ther; 1995 Aug; 274(2):833-41. PubMed ID: 7636747
[TBL] [Abstract][Full Text] [Related]
32. Administration of nicotine to adolescent rats evokes regionally selective upregulation of CNS alpha 7 nicotinic acetylcholine receptors.
Slotkin TA; Cousins MM; Seidler FJ
Brain Res; 2004 Dec; 1030(1):159-63. PubMed ID: 15567348
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of nicotinic receptor function after chronic nicotine infusion.
Marks MJ; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Sep; 266(3):1268-76. PubMed ID: 8371136
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
Lukas RJ
J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological properties of nicotinic acetylcholine receptors on adrenal chromaffin cells and their modification by hypoxic exposure.
Miwa S; Lee K; Narumiya S
Yakubutsu Seishin Kodo; 1993 Jun; 13(3):119-28. PubMed ID: 8237127
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
Lukas RJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):175-82. PubMed ID: 2571716
[TBL] [Abstract][Full Text] [Related]
37. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Piattoni-Kaplan M; Campbell JE; McKenna DG; Molinari E; Hettinger AM; Garvey DS; Wasicak JT; Holladay MW; Williams M; Arneric SP
Neuropharmacology; 1996 Jun; 35(6):725-34. PubMed ID: 8887981
[TBL] [Abstract][Full Text] [Related]
38. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines.
Summers KL; Lippiello P; Giacobini E
Neurochem Res; 1996 Oct; 21(10):1181-6. PubMed ID: 8923478
[TBL] [Abstract][Full Text] [Related]
39. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation.
Abdulla FA; Bradbury E; Calaminici MR; Lippiello PM; Wonnacott S; Gray JA; Sinden JD
Psychopharmacology (Berl); 1996 Apr; 124(4):323-31. PubMed ID: 8739547
[TBL] [Abstract][Full Text] [Related]
40. AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.
Tuan EW; Horti AG; Olson TT; Gao Y; Stockmeier CA; Al-Muhtasib N; Bowman Dalley C; Lewin AE; Wolfe BB; Sahibzada N; Xiao Y; Kellar KJ
Mol Pharmacol; 2015 Oct; 88(4):640-9. PubMed ID: 26162864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
